{"public_id":"cl_e36072955cb6aae6d96c4e007c3424c5","status":"active","superseded_by_public_id":null,"corpus_id":21846518,"text":"Complications of donor leukocyte infusions included acute graft-versus-host disease in 60% of patients, chronic graft-versus-host disease in 60.7% of patients, and pancytopenia in 18.6% of patients.","confidence":0.95,"paper":{"corpus_id":21846518,"title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.","url":"https://sah.borca.ai/papers/21846518"},"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_68809675253de8c55c193716576dcbb1","name":"acute graft-versus-host disease","description":"Acute GVHD occurring after DLI, reported in 60% of patients.","types":["complication"],"url":"https://sah.borca.ai/concepts/co_68809675253de8c55c193716576dcbb1"},{"public_id":"co_b460157f7c8d4c5fdf2d42338ad47b7d","name":"pancytopenia","description":"Low blood cell counts after DLI, reported in 18.6% of patients.","types":["complication"],"url":"https://sah.borca.ai/concepts/co_b460157f7c8d4c5fdf2d42338ad47b7d"},{"public_id":"co_bdc89fea184b433bc627e71b4324df20","name":"chronic graft-versus-host disease","description":"Chronic GVHD occurring after DLI, reported in 60.7% of patients.","types":["complication"],"url":"https://sah.borca.ai/concepts/co_bdc89fea184b433bc627e71b4324df20"},{"public_id":"co_f75e2327123bbc63705ec0d9429939da","name":"donor leukocyte infusions","description":"Transfusion of leukocytes from the original bone marrow donor to treat relapse after allogeneic BMT.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_f75e2327123bbc63705ec0d9429939da"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_e36072955cb6aae6d96c4e007c3424c5"}